ROSELINE WHITTEN: Open Payments
NPI 1922778083 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 40 payments from 11 companies in 2025. Trend: 2023 $31 · 2024 $1,124 · 2025 $1,001
Food & beverage: $902Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $237 |
| Actelion Pharmaceuticals US, Inc. | 7 | $211 |
| Merck Sharp & Dohme LLC | 9 | $157 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Novo Nordisk Inc | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| PFIZER INC. | 2 | $44 |
| Mannkind Corporation | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: LOKELMA, LEQVIO, UPTRAVI, VERQUVO, OPSUMIT, Wegovy, JARDIANCE, WINREVAIR.
Industry payments across GA — which companies pay providers there.
